| 2020 Requests for Applications (RFA's) |
| RFA No. and Title | Status - Expiration |
|---|
| CA20-054 Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed) | ACTIVE - JAN 16, 2021 |
| CA20-053 Genomic Data Analysis Network: Genomic Data Analysis Center (U24 Clinical Trial Not Allowed) | ACTIVE - NOV 13, 2020 |
| CA20-052 Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required) | ACTIVE - NOV 19, 2020 |
| CA20-051 Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) | ACTIVE - JAN 19, 2022 |
| CA20-050 New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed) | ACTIVE - JAN 30, 2021 |
| CA20-049 New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) | ACTIVE - JAN 30, 2021 |
| CA20-048 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) | ACTIVE - NOV 19, 2020 |
| CA20-047 Glioblastoma Therapeutics Network (U19 Clinical Trial Required) | ACTIVE - NOV 20, 2020 |
| CA20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) | ACTIVE - DEC 15, 2021 |
| CA20-045 Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed) | ACTIVE - DEC 17, 2020 |
| CA20-044 Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed) | ACTIVE - OCT 31, 2020 |
| CA20-043 Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) | ACTIVE - JAN 21, 2021 |
| CA20-042 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed) | ACTIVE - NOV 10, 2020 |
| CA20-041 NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed) | ACTIVE - NOV 10, 2020 |
| CA20-040 Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed) | ACTIVE - FEB 18, 2021 |
| CA20-039 Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) | EXPIRED - JUL 23, 2020 |
| CA20-038 Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) | EXPIRED - JUL 23, 2020 |
| CA20-037 Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional) | EXPIRED - SEP 25, 2020 |
| CA20-036 Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional) | EXPIRED - SEP 05, 2020 |
| CA20-035 Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional) | EXPIRED - SEP 05, 2020 |
| CA20-034 NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed) | ACTIVE - NOV 10, 2020 |
| CA20-033 SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) | EXPIRED - SEP 01, 2020 |
| CA20-031 Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed) | ACTIVE - JUN 25, 2021 |
| CA20-029 Metastasis Research Network (U54 Clinical Trial Not Allowed) | ACTIVE - MAY 29, 2021 |
| CA20-028 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) | ACTIVE - JUL 31, 2021 |
| CA20-027 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) | ACTIVE - JUL 31, 2021 |
| CA20-026 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) | EXPIRED - SEP 30, 2020 |
| CA20-025 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | EXPIRED - SEP 30, 2020 |
| CA20-024 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) | EXPIRED - SEP 30, 2020 |
| CA20-023 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) | EXPIRED - SEP 30, 2020 |
| CA20-022 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | EXPIRED - SEP 30, 2020 |
| CA20-021 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) | EXPIRED - SEP 30, 2020 |
| CA20-020 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) | EXPIRED - SEP 30, 2020 |
| CA20-019 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) | EXPIRED - SEP 30, 2020 |
| CA20-018 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) | EXPIRED - SEP 30, 2020 |
| CA20-017 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) | EXPIRED - SEP 30, 2020 |
| CA20-013 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) | ACTIVE - NOV 19, 2020 |
| CA20-012 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) | ACTIVE - NOV 19, 2020 |
| CA20-011 Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) | ACTIVE - NOV 19, 2020 |
| CA20-010 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | ACTIVE - NOV 19, 2020 |
| CA20-009 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | ACTIVE - NOV 19, 2020 |
| CA20-008 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | ACTIVE - NOV 19, 2020 |
| CA20-007 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) | ACTIVE - NOV 19, 2020 |
| CA20-005 Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional) | ACTIVE - NOV 18, 2020 |
| CA20-004 Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) | ACTIVE - NOV 18, 2020 |
